Funds & ETF’s

Newswire

[ July 22, 2026 ] Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma? Arena Signals
[ July 22, 2026 ] Intellia Therapeutics (NASDAQ: NTLA) Stock Analysis: Can CRISPR Deliver Its First Blockbuster? Arena Signals
[ July 20, 2026 ] Fortress Biotech (NASDAQ: FBIO) Stock Analysis: Building a Biotech Empire—One Deal at a Time Arena Signals
[ July 17, 2026 ] Fastly (NASDAQ: FSLY) Stock Analysis: Edge Platform Reaches an Inflection Point Arena Signals
[ July 17, 2026 ] Innoviz Technologies (NASDAQ: INVZ) Stock Analysis: Building the Perception Layer for the Physical AI Revolution Arena Signals
[ July 17, 2026 ] Neuronetics (NASDAQ: STIM) Stock Analysis: Building an Integrated Mental Health Treatment Platform Arena Signals
[ July 16, 2026 ] AST SpaceMobile (NASDAQ: ASTS) Stock Analysis: Building World’s First Space-Based Broadband Provider Arena Signals
[ July 14, 2026 ] GameStop (NYSE: GME) Stock Analysis: Profitable Turnaround — Is Ryan Cohen This Generation’s Warren Buffett? Arena Signals
[ July 14, 2026 ] Quantum (NASDAQ: QMCO) Stock Analysis: Rebuilding the Data Infrastructure Company for the AI Era Arena Signals
[ July 14, 2026 ] Expensify (NASDAQ: EXFY) Stock Analysis: Building the AI-Native Financial Superapp for Business Spending Arena Signals

Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma?

July 22, 2026 Comments Off on Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma?

Liquidia (NASDAQ: LQDA): Can Liquidia Become the Next Great Specialty Pharma? Liquidia (NASDAQ: LQDA): Can Liquidia Become the Next Great Specialty Pharma? Arena Signals report · Pulmonary vascular disease · Specialty pharmaceuticals · Inhaled prostacyclin [...]
Intellia Therapeutics (NASDAQ: NTLA) Stock Analysis: Can CRISPR Deliver Its First Blockbuster?

July 22, 2026 Comments Off on Intellia Therapeutics (NASDAQ: NTLA) Stock Analysis: Can CRISPR Deliver Its First Blockbuster?
Fortress Biotech (NASDAQ: FBIO) Stock Analysis: Building a Biotech Empire—One Deal at a Time

July 20, 2026 Comments Off on Fortress Biotech (NASDAQ: FBIO) Stock Analysis: Building a Biotech Empire—One Deal at a Time
Fastly (NASDAQ: FSLY) Stock Analysis: Edge Platform Reaches an Inflection Point

July 17, 2026 Comments Off on Fastly (NASDAQ: FSLY) Stock Analysis: Edge Platform Reaches an Inflection Point
Innoviz Technologies (NASDAQ: INVZ) Stock Analysis: Building the Perception Layer for the Physical AI Revolution

July 17, 2026 Comments Off on Innoviz Technologies (NASDAQ: INVZ) Stock Analysis: Building the Perception Layer for the Physical AI Revolution

Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma?

July 22, 2026 Comments Off on Liquidia (NASDAQ: LQDA) Stock Analysis: Can Liquidia Become the Next Great Specialty Pharma?

Liquidia (NASDAQ: LQDA): Can Liquidia Become the Next Great Specialty Pharma? Liquidia (NASDAQ: LQDA): Can Liquidia Become the Next Great Specialty Pharma? Arena Signals report · Pulmonary vascular disease · Specialty pharmaceuticals · Inhaled prostacyclin [...]
Post 2

February 9, 2009 Comments Off on Post 2
Palm(NASDAQ: PALM) builds momentum;

February 9, 2009 Comments Off on Palm(NASDAQ: PALM) builds momentum;
Post 4

February 9, 2009 Comments Off on Post 4
Value Investing Opportunities (Prospect List Here)

February 10, 2009 Comments Off on Value Investing Opportunities (Prospect List Here)

Carbonium Core (NASDAQ: TOMZ) CEO Details Strategy to Supply Critical Material Powering the AI-Driven Nuclear Renaissance

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) CEO Details Strategy to Supply Critical Material Powering the AI-Driven Nuclear Renaissance
TOMI Environmental (NASDAQ: TOMZ) Announces Definitive Agreement to Merge with Carbonium Core

July 1, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Announces Definitive Agreement to Merge with Carbonium Core
TOMI (NASDAQ: TOMZ) Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending

June 23, 2026 Comments Off on TOMI (NASDAQ: TOMZ) Reports Accelerating SteraMist Adoption as Ebola Outbreaks and Global Biosecurity Threats Drive Preparedness Spending
TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

June 10, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets
Myseum.AI (NASDAQ: MYSE) Announces Sponsorship and Panel Participation at Visual 1st 2026 Conference for Global Photo and Video industry

June 10, 2026 Comments Off on Myseum.AI (NASDAQ: MYSE) Announces Sponsorship and Panel Participation at Visual 1st 2026 Conference for Global Photo and Video industry
TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

June 8, 2026 Comments Off on TOMI Environmental (NASDAQ: TOMZ) Targets Drone-Enabled SteraMist® Technology for High-Growth AI, Autonomous Robotics and Biosecurity Markets

Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?
Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite

July 1, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite
FIFA World Cup + Biosecurity + Robotics = The $TOMZ Opportunity

June 5, 2026 Comments Off on FIFA World Cup + Biosecurity + Robotics = The $TOMZ Opportunity
Next Super Stock (NASDAQ: TOMZ) We Saw This Before: Axon Went From $1.50 to $800+

June 4, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) We Saw This Before: Axon Went From $1.50 to $800+

Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?

July 7, 2026 Comments Off on Carbonium Core (NASDAQ: TOMZ) Targets $1.5 Billion Annual Revenue Opportunity—Could It Become the MP Materials of Nuclear-Grade Graphite?
Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite

July 1, 2026 Comments Off on Next Super Stock (NASDAQ: TOMZ) Path to $1.5 Billion Revenue Potential w Nuclear Graphite
Next Super Stock Myseum (NASDAQ: MYSE) $100 Billion Opportunity: $MYSE is What Instagram was Meant to Be!

April 1, 2026 Comments Off on Next Super Stock Myseum (NASDAQ: MYSE) $100 Billion Opportunity: $MYSE is What Instagram was Meant to Be!
Next Super Stock (NASDAQ: CXAI) Driving AI Workplace Transformation – $100+ BILLION Market

December 16, 2025 Comments Off on Next Super Stock (NASDAQ: CXAI) Driving AI Workplace Transformation – $100+ BILLION Market

Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.